APA (7th ed.) Citation

M, D. R., E, I., E, B., EJ, B., RHJ, M., G, C., & R, D. (2026). Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical Rationale. Drugs, 86(6), 871. https://doi.org/10.1007/s40265-026-02289-y

Chicago Style (17th ed.) Citation

M, Del Re, Inglese E, Bria E, Blok EJ, Mathijssen RHJ, Curigliano G, and Danesi R. "Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical Rationale." Drugs 86, no. 6 (2026): 871. https://doi.org/10.1007/s40265-026-02289-y.

MLA (9th ed.) Citation

M, Del Re, et al. "Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical Rationale." Drugs, vol. 86, no. 6, 2026, p. 871, https://doi.org/10.1007/s40265-026-02289-y.